Article Text

Download PDFPDF
Management of a child with suspected acute septic arthritis
  1. M Pääkkönen1,2,
  2. H Peltola1
  1. 1University of Helsinki and Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland
  2. 2Department of Surgery, Turku University Hospital, Turku, Finland
  1. Correspondence to Markus Pääkkönen, Department of Surgery, Turku University Hospital, PO Box 52, 20521 Turku, Finland; Markus.Paakkonen{at}


Acute septic arthritis of childhood is a potentially devastating disease that causes permanent disability and can result in death. Traditional treatment consists of a prolonged course of intravenous antibiotics combined with aggressive surgery. However, this approach is challenged by trials showing satisfactory outcomes with shorter treatment and less invasive surgery. Diagnostic arthrocentesis alone and an antibiotic for a fortnight, including initial intravenous administration for 2–4 days, suffice in most non-neonatal cases. A good penetrating agent, such as clindamycin or a first-generation cephalosporin, exceptionally high doses, and administration four times a day are probably key factors. If the symptoms and signs subside within a few days, and the serum C-reactive protein level drops below 20 mg/l, the antibiotic can usually be safely discontinued. Methicillin-resistant Staphylococcus aureus is a concern, but fortunately, most strains have retained susceptibility to clindamycin. The above guidance is not applicable to neonates and immunocompromised patients who may require a different approach.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests None.

  • Provenance and peer review Commissioned; externally peer reviewed.